Drug information for FIRAZYR

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
INJECTABLE; SUBCUTANEOUS	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	Prescription	(Reference Drug)	ICATIBANT ACETATE	icatibant	SHIRE ORPHAN THERAP	22150 2011-10-03 Review 2011-08-29 Letter 2011-08-26 Label

Drug Adverse Effects information for FIRAZYR

Role code	Indications	Reaction	# Reports
PS	HAEMANGIOMA CONGENITAL	ABDOMINAL PAIN UPPER	1
PS	HAEMANGIOMA CONGENITAL	FATIGUE	1
PS	HAEMANGIOMA CONGENITAL	LOSS OF CONSCIOUSNESS	1
PS	HAEMANGIOMA CONGENITAL	MUSCLE SPASMS	1
PS	HAEMANGIOMA CONGENITAL	OEDEMA PERIPHERAL	1
PS	HAEMANGIOMA CONGENITAL	PAIN IN EXTREMITY	1
PS	HEREDITARY ANGIOEDEMA	ARTERIOSPASM CORONARY	3
PS	HEREDITARY ANGIOEDEMA	BLOOD CREATININE INCREASED	2
PS	HEREDITARY ANGIOEDEMA	CHEST PAIN	2
PS	HEREDITARY ANGIOEDEMA	ELECTROCARDIOGRAM ST SEGMENT ELEVATION	2
PS	HEREDITARY ANGIOEDEMA	HYPERTENSION	2
PS	HEREDITARY ANGIOEDEMA	RASH GENERALISED	1
PS	HEREDITARY ANGIOEDEMA	SWELLING	1
PS	HEREDITARY ANGIOEDEMA	TACHYCARDIA	2
PS	HEREDITARY ANGIOEDEMA	URTICARIA	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	ABDOMINAL PAIN UPPER	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	FATIGUE	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	LOSS OF CONSCIOUSNESS	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	MUSCLE SPASMS	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	OEDEMA PERIPHERAL	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	PAIN IN EXTREMITY	1

Ads by Google